Condition
Hyperuricemia
ClinicalTrials.gov condition label
Explore related research
Search across original and mapped recordsSearch results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 29 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
29 shownProspective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision Support Tools in the Management of Patients With "Four Highs" (Hypertension, Hyperglycemia, Hyperlipidemia, Hyperuricemia)NCT07400549 · 2025-06-01
RECRUITINGRisk Factors and Multiomics Study of Chronic Kidney Disease Caused by Metabolic DiseasesNCT05476627 · 2022-07-01
RECRUITINGMazdutide for Weight Management and Gout in Adults With ObesityNCT07824895 · 2026-09-15
NOT_YET_RECRUITINGChronic Kidney Disease and Metabolic Disorders in the ElderlyNCT07494526 · 2026-04-01
NOT_YET_RECRUITINGIs There a Relationship Between Uric Acid Level and Liver Fibrosis in Obese PatientsNCT07168551 · 2025-10-01
NOT_YET_RECRUITINGMetabolically Healthy Obesity Increases the Risks of MASLD and HyperuricemiaNCT07001865 · 2025-04-01
ENROLLING_BY_INVITATIONEffectiveness of Digital Health Intervention on Community Health Care in Middle-aged and Older Population in TaiwanNCT07238257 · 2023-12-01
COMPLETEDResearch and Development of a New Technology for Detection of Abnormal Excretion of Intestinal Uric Acid Involved in the Incidence of GoutNCT04953533 · 2021-07-06
UNKNOWNNon-Inferiority Study of Aliskiren vs Losartan in the Treatment of Hypertension With HyperuricemiaNCT06718062 · 2021-05-01
COMPLETEDHyperuricemia and Diabetic NephropathyNCT04799925 · 2021-04-15
UNKNOWNHmong Microbiome ANd Gout, Obesity, Vitamin C (HMANGO-C)NCT04938024 · 2021-03-28
COMPLETEDXanthine Oxidase and Uric Acid Origin in Preeclamptic WomenNCT04463940 · 2020-06-30
UNKNOWNUric Acid Lowering Trial in Youth Onset T2DNCT03899883 · 2020-01-01
COMPLETEDSex-related Differences in Arterial Stiffness in Type 2 Diabetics: Role of Uric AcidNCT03648996 · 2018-11-01
COMPLETEDThe Diet Gout TrialNCT03569020 · 2018-08-07
COMPLETEDIntensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With AlbuminuriaNCT03118739 · 2017-05-18
COMPLETEDPharmacogenetics of SGLT2 InhibitorsNCT02462421 · 2015-06-01
TERMINATEDEffect of Allopurinol Treatment on Insulin ResistanceNCT02008968 · 2013-12-01
UNKNOWNLong-term Prednisone Use for End-stage Heart FailureNCT02282683 · 2013-12-01
UNKNOWNEffect of Quercetin Supplements on Healthy Males: a Four-Week Randomized Cross-Over TrialNCT01881919 · 2013-02-01
COMPLETEDTart Cherry Juice and Markers of Inflammation, CVD, and DiabetesNCT03636529 · 2010-06-01
COMPLETEDThe Role Of Fructose and Uric Acid In the Development of Obesity and Metabolic SyndromeNCT00868673 · 2009-03-01
COMPLETEDPrednisone for Heart Failure Patients With HyperuricemiaNCT00919243 · 2009-02-01
COMPLETEDPrimary Prevention of Hypertension in Obese AdolescentsNCT00288158 · 2008-09-01
COMPLETEDEffect of Reducing Uric Acid on Insulin Sensitivity and Oxidative StatusNCT01931527 · 2006-07-01
COMPLETEDRasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy PatientsNCT00186940 · 2005-03-01
COMPLETEDTreatment of Hyperuricemia in Patients With Heart FailureNCT00422318 · 2004-01-01
COMPLETEDReversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Postmenopausal Women.NCT03921736 · 2000-01-10
COMPLETEDAllopurinol in Chronic Heart FailureNCT00997542
COMPLETEDCommon interventions
AllopurinolDRUG4PlaceboDRUG4No interventionOTHER3prednisoneDRUG2RasburicaseDRUG2*Imaging Studies:* 1- Ultrasound 2 - FibroScanRADIATION1*Lab Methods:* 1- Serum Uric Acid levels 2-Liver Function Tests 3- Lipid Profile . 4- Haemoglobin A1c level . 5- Serum glucose level .DIAGNOSTIC_TEST1AliskirenDRUG1allopurinol 300 mg./dayDRUG1Benzbromarone (drug)DRUG1BiomarkersDIAGNOSTIC_TEST1CanagliflozinDRUG1ControlDIETARY_SUPPLEMENT1Digital Health Program with Smart DevicesDEVICE1Enhanced ControlBEHAVIORAL1Enhanced Mini-Program InterventionBEHAVIORAL1Estracomb TTSDRUG1FebuxostatDRUG1HydrochlorothiazideDRUG1Instruments:* 1- *Automated Analyzers*: Used for blood tests, such as serum uric acid and liver function tests.DEVICE1LosartanDRUG1low fructoseDIETARY_SUPPLEMENT1Low-fructose diet, isocaloricOTHER1Low-fructose, hypocaloricOTHER1MazdutideDRUG1
Mapped drugs appearing in these trials
Shared trial participation only; not evidence of efficacy or approval.
Leading sponsors
Assiut University
2
Hebei Medical University
2
Anna Posadzy-Małaczyńska
1
AstraZeneca
1
Barzilai Medical Center
1
Chang Gung Memorial Hospital
1
China National Center for Cardiovascular Diseases
1
Chinese PLA General Hospital
1
Hansung University
1
Hongwei Jiang
1
Instituto Nacional de Cardiologia Ignacio Chavez
1
Istanbul Medeniyet University
1
Johns Hopkins University
1
National Heart and Lung Institute
1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
1
Trial status mix
COMPLETED17
UNKNOWN5
NOT_YET_RECRUITING3
RECRUITING2
ENROLLING_BY_INVITATION1
TERMINATED1
Phase mix
NA8
PHASE47
PHASE25
EARLY_PHASE11
PHASE31
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.